Nymox Pharmaceutical
NYMX
#10337
Rank
โ‚ฌ15.69 M
Marketcap
Country
0,17ย โ‚ฌ
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

Earnings for Nymox Pharmaceutical (NYMX)

Earnings in 2023 (TTM): -โ‚ฌ2.12 Million

According to Nymox Pharmaceutical's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -โ‚ฌ5.62 Million, an increase over its 2021 earnings that were of -โ‚ฌ10.74 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nymox Pharmaceutical from 1997 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -โ‚ฌ2.12 Million-62.33%
2022 -โ‚ฌ5.62 Million-47.71%
2021 -โ‚ฌ10.74 Million6.61%
2020 -โ‚ฌ10.07 Million-10.91%
2019 -โ‚ฌ11.3 Million24.24%
2018 -โ‚ฌ9.1 Million-20.03%
2017 -โ‚ฌ11.38 Million2.71%
2016 -โ‚ฌ11.08 Million-63.86%
2015 -โ‚ฌ30.64 Million674.44%
2014 -โ‚ฌ3.96 Million-6.11%
2013 -โ‚ฌ4.22 Million-35.66%
2012 -โ‚ฌ6.55 Million-20.76%
2011 -โ‚ฌ8.27 Million38.33%
2010 -โ‚ฌ5.98 Million35.59%
2009 -โ‚ฌ4.41 Million11.8%
2008 -โ‚ฌ3.95 Million-12.94%
2007 -โ‚ฌ4.53 Million8.85%
2006 -โ‚ฌ4.16 Million36.5%
2005 -โ‚ฌ3.05 Million-4.4%
2004 -โ‚ฌ3.19 Million-14.58%
2003 -โ‚ฌ3.74 Million
2001 -โ‚ฌ2.74 Million-20.54%
2000 -โ‚ฌ3.45 Million21.72%
1999 -โ‚ฌ2.84 Million-25.56%
1998 -โ‚ฌ3.81 Million101.3%
1997 -โ‚ฌ1.89 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.33 B-1,202,274.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ9.10 B-490,197.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚ฌ6.99 B-376,638.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ26.76 B-1,440,405.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚ฌ1.18 B-63,774.22%๐Ÿ‡บ๐Ÿ‡ธ USA